Table 1.
Baseline characteristics of the enrolled breast cancer patients.
| Characteristics | No. (%) |
|---|---|
| Age | |
| <50 | 39 (13) |
| ≥50 | 260 (87) |
| Oestrogen receptor | |
| Negative | 80 (27) |
| Positive | 219 (73) |
| Tumour size (mm) | |
| <20 | 201 (67) |
| ≥20 | 98 (33) |
| Nuclear grade | |
| 1 | 145 (48) |
| 2, 3 | 154 (52) |
| HER2 | |
| Negative | 248 (83) |
| Positive | 51 (17) |
| Progesterone receptor | |
| Negative | 125 (42) |
| Positive | 174 (48) |
| Lymph node involvement | |
| Negative | 229 (77) |
| Positive | 70 (23) |
| PDW/P | |
| <0.59 | 194 (65) |
| ≥0.59 | 105 (35) |
| RDW | |
| <13.7 | 216 (72) |
| ≥13.7 | 83 (28) |
| RPR | |
| <0.71 | 225 (75) |
| ≥0.71 | 74 (25) |
Abbreviations: No, number; HER2, human epidermal growth factor receptor 2; PDW/P, platelet distribution width to platelet count ratio; RDW, red cell distribution width; RPR, red cell distribution width to platelet count ratio.